Citigroup’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,800
| Closed | -$1.41M | – | 5649 |
|
|
2022
Q4 | $1.41M | Buy |
+18,800
| New | +$1.34M | ﹤0.01% | 2312 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$36K | – | 6751 |
|
|
2020
Q4 | $36K | Sell |
500
-1,300
| -72% | -$91.8K | ﹤0.01% | 6262 |
|
|
2020
Q3 | $120K | Sell |
1,800
-32,100
| -95% | -$2.03M | ﹤0.01% | 4970 |
|
|
2020
Q2 | $1.93M | Sell |
33,900
-10,900
| -24% | -$535K | ﹤0.01% | 2847 |
|
|
2020
Q1 | $1.57M | Sell |
44,800
-52,400
| -54% | -$2.49M | ﹤0.01% | 2719 |
|
|
2019
Q4 | $5.08M | Sell |
97,200
-1,300
| -1% | -$64.7K | ﹤0.01% | 2018 |
|
|
2019
Q3 | $4.97M | Buy |
98,500
+27,500
| +39% | +$1.35M | ﹤0.01% | 1946 |
|
|
2019
Q2 | $3.41M | Buy |
71,000
+9,000
| +15% | +$416K | ﹤0.01% | 2294 |
|
|
2019
Q1 | $3M | Buy |
62,000
+30,100
| +94% | +$1.36M | ﹤0.01% | 2228 |
|
|
2018
Q4 | $1.31M | Buy |
31,900
+13,800
| +76% | +$566K | ﹤0.01% | 3119 |
|
|
2018
Q3 | $742K | Sell |
18,100
-17,500
| -49% | -$707K | ﹤0.01% | 3818 |
|
|
2018
Q2 | $1.42M | Sell |
35,600
-4,200
| -11% | -$162K | ﹤0.01% | 3016 |
|
|
2018
Q1 | $1.49M | Buy |
39,800
+29,700
| +294% | +$1.2M | ﹤0.01% | 2879 |
|
|
2017
Q4 | $432K | Buy |
10,100
+7,100
| +237% | +$283K | ﹤0.01% | 4248 |
|
|
2017
Q3 | $110K | Buy |
3,000
+100
| +3% | +$4.04K | ﹤0.01% | 5489 |
|
|
2017
Q2 | $132K | Sell |
2,900
-2,800
| -49% | -$124K | ﹤0.01% | 5124 |
|
|
2017
Q1 | $243K | Sell |
5,700
-28,100
| -83% | -$1.15M | ﹤0.01% | 4500 |
|
|
2016
Q4 | $1.36M | Buy |
33,800
+29,500
| +686% | +$1.14M | ﹤0.01% | 3382 |
|
|
2016
Q3 | $167K | Sell |
4,300
-500
| -10% | -$18.9K | ﹤0.01% | 4805 |
|
|
2016
Q2 | $166K | Sell |
4,800
-3,800
| -44% | -$132K | ﹤0.01% | 4664 |
|
|
2016
Q1 | $297K | Sell |
8,600
-10,000
| -54% | -$349K | ﹤0.01% | 4702 |
|
|
2015
Q4 | $720K | Sell |
18,600
-13,600
| -42% | -$529K | ﹤0.01% | 3485 |
|
|
2015
Q3 | $1.26M | Buy |
32,200
+10,500
| +48% | +$416K | ﹤0.01% | 2859 |
|
|
2015
Q2 | $826K | Buy |
21,700
+6,800
| +46% | +$238K | ﹤0.01% | 3291 |
|
|
2015
Q1 | $492K | Sell |
14,900
-21,800
| -59% | -$669K | ﹤0.01% | 3759 |
|
|
2014
Q4 | $981K | Buy |
36,700
+1,000
| +3% | +$25.8K | ﹤0.01% | 3156 |
|
|
2014
Q3 | $869K | Sell |
35,700
-7,700
| -18% | -$194K | ﹤0.01% | 3109 |
|
|
2014
Q2 | $1.1M | Sell |
43,400
-5,500
| -11% | -$129K | ﹤0.01% | 2897 |
|
|
2014
Q1 | $1.05M | Sell |
48,900
-9,300
| -16% | -$201K | ﹤0.01% | 2839 |
|
|
2013
Q4 | $1.3M | Sell |
58,200
-79,900
| -58% | -$1.76M | ﹤0.01% | 2947 |
|
|
2013
Q3 | $2.85M | Buy |
138,100
+21,000
| +18% | +$447K | ﹤0.01% | 2217 |
|
|
2013
Q2 | $2.26M | Buy |
+117,100
| New | +$2.45M | ﹤0.01% | 2296 |
|
Other funds holding HOLX
VCM
HI
VPM
Citigroup's HOLX Position: Q1 2026 in Review
Citigroup increased its Hologic (HOLX) stake by 36% in Q1 2026, buying an estimated $10.7M and bringing the position to 537,511 shares worth $40.6M. The position accounts for 0.02% of the portfolio, ranked #725.
Citigroup first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.2M in Q2 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Citigroup held 537,511 shares of Hologic worth $40.6M as of Q1 2026.
- Citigroup bought 142,582 Hologic shares in Q1 2026, an estimated $10.7M.
- Hologic made up 0.02% of Citigroup's portfolio in Q1 2026, its #725 holding.
- Citigroup first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Hologic position peaked at $85.2M in Q2 2025.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.